Serum levels of interleukins 8 and 10, interferon γ, granulocyte-macrophage colony stimulating factor and soluble CD23 in patients with primary sclerosing cholangitis

Autoimmunity

Volumn 26, Issue 4, 1997, Pages 223-229

  Bansal, A S ^a   Thomson, A ^b   Steadman, C ^b   Le Gros, G ^a   Hogan, P G ^a   Kerlin, P ^b   Lynch, S ^b   Strong, R ^b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b PRINCESS ALEXANDRA HOSPITAL   (Australia)

Author keywords

Granulocyte macrophage; Interferon ; Interleukins 8 and 10

Indexed keywords

CD23 ANTIGEN; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 8;

ADOLESCENT; ADULT; ALCOHOL LIVER CIRRHOSIS; ARTICLE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMORAL IMMUNITY; MACROPHAGE; MALE; MONOCYTE; PRIMARY SCLEROSING CHOLANGITIS;

EID: 0031413160     PISSN: 08916934     EISSN: None     Source Type: Journal    
DOI: 10.3109/08916939709008028     Document Type: Article

References (27)

1. Snook, J. A., Chapman, R. W., Fleming, K. and Jewell, D. P. (1989). Anti-neutrophil nuclear antibody in ulcerative colitis, Crohn's disease and primary sclerosing cholangitis. Clin Exp Imm., 76, 30-33.
2. Das, K. M., Vecchi, M. and Sakamaki, S. (1990). A shared and unique epitope(s) on human colon, skin, and biliary epithelium detected by monoclonal antibody. Gastroenterology, 98, 464-69.
3. Siebold, F., Slametschka, D., Gregor, M. and Weber, P. (1994). Neutrophil autoantibodies: A genetic marker in primary sclerosing cholangitis and ulcerative colitis. Gastroenterology, 107, 532-36.
4. Seibold, F., Weber. R., Berg, P. A. and Wiedmann, K. H. (1992). Clinical significance of antibodies against neutrophils in patients with inflammatory bowel disease and primary sclerosing cholangitis. Gut, 33, 657-62.
5. Duerr, R. H., Targan, S. R., Landers, C. J., Larusso, N. F., Lindsay, K. L., Wiesner, R. H. and Shanahan, F. (1991). Neutrophil cytoplasmic antibodies: A link between primary sclerosing cholangitis and ulcerative colitis. Gastroenterology, 100, 1385-1391.
6. Chapman, R. W., Varghese, Z., Gaul, R., Patrl, G., Kokinon, N. and Sherlock, S. (1983). Association of primary sclerosing cholangitis with HLA B8. Gut, 24, 38-41.
7. Doanldson, P. T., Farrant, J. M., Wilkinson, M. L., Hayllar, K., Portmann, B. C. and Williams, R. (1991). Dual association of HLA DR2 and DR3 with primary sclerosing cholangitis. Hepatology, 13, 129-133.
8. Weisner, R. H., LaRusso, N. F., Ludwig, J. and Dickson, E. R. (1985). Comparison of the clinicopathologic features of primary sclerosing cholangitis and primary biliary cirrhosis. Gastroenterology, 88, 108-114.
9. Senaldi, G., Donaldson, P. T., Magrin, S., Farrant, J. M., Alexander, G. J., Vergani, D., et al. (1989). Activation of the complement system in primary sclerosing cholangitis. Gastroenterology, 97, 1430-1434.
10. Minuk, G. Y., Angus, M., Brickman, C. M., Lawley, T. J., Frank, M. M., Hoofnagle, J. H., et al. (1985). Abnormal clearance of immune complexes from the circulation of patients with primary sclerosing cholangitis. Gastroenterology, 88, 166-70.
11. Bansal, A. S., Roberts, T., Hay, E. M., Kay, R., Pumphrey, R. S. H. and Wilson, P. B. (1992). Soluble CD23 levels are elevated in the serum of patients with primary Sjögrens syndrome and SLE. Clin Exp Immunol, 89, 452-55.
12. Delespesse, G., Suler, U., Mossalayi, D., Bettler, B., Sarfatio, M., Sarfati, M., Hofstetter, H., Kilcherre, E., Debre, P. and Dalloul, A. A. (1991). Expression, structure and function of the CD23 antigen. Adv Immunol., 49, 149-91.
13. Gordon, J. (1992). CD23 and B cell activation. Clin Exp Allergy, 22, 199-204.
14. Bansal, A. S., Cochrane, S., Haeney, M. R., Bhavnani, M., Pumphrey, R. S. H. and Wilson, P. B. (1994). Serum soluble CD23 in conditions with hypogammaglobulinaemia and varying B cell numbers. Clin Exp Immunol., 97, 239-41.
15. Mossalayi, M. D., Dalloul, A. H., Fourcade, C., Arcock, M., Merle-Beral, H., Hoffstetter, H. and Debre, P. (1991). The role of CD23 on early human haematopoietic precursors. Monogr Allergy, 29, 178-85.
16. Bansal, A. S., MacGregor, A. J., Pumphrey, R. S. H., Ollier, W. E. R., Silman, A. J. and Wilson, P. B. (1994). Increased levels of sCD23 in rheumatoid arthritis are related to disease status. Clin Exp Rheumatol., 12, 281-85.
17. Bansal, A. S., Ollier, W., Marsh, M. N., Pumphrey, R. S. H. and Wilson, P. B. (1993). Variations in serum sCD23 in conditions with either enhanced humoral or cell-mediated immunity. Immunology, 79, 285-89.
18. Niessner, M. and Volk, B. A. (1995). Altered Th1/Th2 cytokine profiles in the intestinal mucosa of patients with inflammatory bowel disease as assessed by quantitative reversed transcribed polymerase chain reaction (RT-PCR). Clin Exp Immunol., 101, 428-35.
19. Sasaki, T., Hiwatashi, N., Yamazaki, H., Noguchi, M. and Toypota, T. (1992). The role of interferon y in the pathogenesis of Crohn's disease. Gastroenterologia Japonica, 27, 29-35.
20. Al-Janadi, M., Al-Wabel, A. and Raziuddin, S. (1994). Soluble CD23 and Interleukin-4 levels in autoimmune chronic active hepatitis and systemic lupus erythematosus. Clin Imm and Immunopathy, 71, 33-37.
21. Cush, J. J., Splawski, J. B., Thomas, R., McFarlin, J. E., Schulze-Koops, H., Davis, L. S., Fujita, K. and Lipsky, P. E. (1995). Elevated interleukin-10 in patients with rheumatoid arthritis. Arthritis Rheumatism, 38, 96-104.
22. Llorente, L., Richaud-Patin, Y., Fior, R., Alcocer-Varela, J., Wijdenes, O., Fourrier, B. M., Galanaud, P. and Emilie, D. (1994). In vivo production of interleukin-10 by non-T cells in rheumatoid arthritis, Sjogrens syndrome and systemic lupus erythematosus. Arthritis Rheumatism, 37, 1647-1655.
23. Kucharzik, T., Stoll, R., Lügering, N. and Domschke, W. (1995). Circulating antiinflammatory cytokine IL10 in patients with inflammatory bowel disease. Clin Exp Imm., 101, 452-456.
24. Niessner, M. and Volk, B. A. (1995). Altered Th1/Th2 cytokine profiles in the intestinal mucosa of patients with inflammatory bowel disease as assessed by quantitative reversed transcribed polymerase chain reaction (RT-PCR). Clin Exp Imm., 101, 428-435.
25. Howard, M. and O'Garra, A. (1992). Biological properties of interleukin 10. Imm Today, 13, 198-200.
26. Schreiber, S., Heinig, T., Heinz-Günther, T. and Raedler, A. (1995). Immunoregulatory role of interleukin 10 in patients with inflammatory bowel disease. Gastroenterologe, 108, 1434-44.
27. Saviege, J. A., Davies, D. J. and Gatenby, P. A. (1994). Anti-neutrophil cytoplasmic antibodies (ANCA): Their detection and significance: Report from workshops. Pathology, 26, 186-193.